The high The-0504 anticancer activity reported in this work can be ascribed to its remarkable selectivity for cancer cells that express high levels of CD71 with respect to normal cells, as demonstrated by the absence of treatment-related toxicity in mice and rats at clinically-relevant doses. Here, TFRC is linked to cancer.